BRPI0906064B8 - peptídeo, processo para obtenção de um peptídeo de fórmula geral (i), composição cosmética ou farmacêutica e uso de um peptídeo de fórmula geral (i) - Google Patents
peptídeo, processo para obtenção de um peptídeo de fórmula geral (i), composição cosmética ou farmacêutica e uso de um peptídeo de fórmula geral (i)Info
- Publication number
- BRPI0906064B8 BRPI0906064B8 BRPI0906064A BRPI0906064A BRPI0906064B8 BR PI0906064 B8 BRPI0906064 B8 BR PI0906064B8 BR PI0906064 A BRPI0906064 A BR PI0906064A BR PI0906064 A BRPI0906064 A BR PI0906064A BR PI0906064 B8 BRPI0906064 B8 BR PI0906064B8
- Authority
- BR
- Brazil
- Prior art keywords
- peptide
- general formula
- cosmetic
- obtaining
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
Abstract
peptídeo, processo para obtenção de um peptídeo de fórmula geral (i), composição cosmética ou farmacêutica e uso de um peptídeo de fórmula geral (i) a presente invenção refere-se a peptídeos de fórmula geral (i): r1-aa1-aa2-aa3-aa4 - r2, estereoisômeros, misturas ou os sais cosmeticamente ou farmaceuticamente aceitáveis destes, a um método para obtenção dos mesmos, as composições cosméticas ou farmacêuticas que os contêm, e a seu uso para o tratamento e/ou cuidado dessas condições, distúrbios e/ou patologias da pele, mucosas e/ou couro cabeludo resultantes a partir de super-expressão de metaloproteinases de matriz (mmp) ou um aumento na atividade de mmp.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200800597A ES2330291B1 (es) | 2008-02-29 | 2008-02-29 | Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas. |
PCT/EP2009/001419 WO2009106343A1 (en) | 2008-02-29 | 2009-02-27 | Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0906064A2 BRPI0906064A2 (pt) | 2015-06-30 |
BRPI0906064B1 BRPI0906064B1 (pt) | 2020-04-14 |
BRPI0906064B8 true BRPI0906064B8 (pt) | 2021-05-25 |
Family
ID=40674197
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0906064A BRPI0906064B8 (pt) | 2008-02-29 | 2009-02-27 | peptídeo, processo para obtenção de um peptídeo de fórmula geral (i), composição cosmética ou farmacêutica e uso de um peptídeo de fórmula geral (i) |
Country Status (18)
Country | Link |
---|---|
US (1) | US9315564B2 (pt) |
EP (1) | EP2254908B1 (pt) |
JP (1) | JP5613062B2 (pt) |
KR (1) | KR101656533B1 (pt) |
CN (1) | CN102015764B (pt) |
AU (1) | AU2009218680B2 (pt) |
BR (1) | BRPI0906064B8 (pt) |
CA (1) | CA2716650A1 (pt) |
DK (1) | DK2254908T3 (pt) |
ES (2) | ES2330291B1 (pt) |
HK (1) | HK1151301A1 (pt) |
IL (1) | IL207808A (pt) |
MX (1) | MX2010009485A (pt) |
PL (1) | PL2254908T3 (pt) |
PT (1) | PT2254908E (pt) |
SI (1) | SI2254908T1 (pt) |
WO (1) | WO2009106343A1 (pt) |
ZA (1) | ZA201006889B (pt) |
Families Citing this family (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US7700076B2 (en) * | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
US20070292355A1 (en) * | 2002-10-25 | 2007-12-20 | Foamix Ltd. | Anti-infection augmentation foamable compositions and kit and uses thereof |
US20060193789A1 (en) * | 2002-10-25 | 2006-08-31 | Foamix Ltd. | Film forming foamable composition |
US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
US10117812B2 (en) * | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US8119109B2 (en) * | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
US20070292359A1 (en) * | 2002-10-25 | 2007-12-20 | Foamix Ltd. | Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof |
US20080206161A1 (en) * | 2002-10-25 | 2008-08-28 | Dov Tamarkin | Quiescent foamable compositions, steroids, kits and uses thereof |
US20050271596A1 (en) * | 2002-10-25 | 2005-12-08 | Foamix Ltd. | Vasoactive kit and composition and uses thereof |
US20050186142A1 (en) * | 2002-10-25 | 2005-08-25 | Foamix Ltd. | Kit and composition of imidazole with enhanced bioavailability |
US20060233721A1 (en) * | 2002-10-25 | 2006-10-19 | Foamix Ltd. | Foam containing unique oil globules |
US8119150B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Non-flammable insecticide composition and uses thereof |
MXPA05004278A (es) * | 2002-10-25 | 2005-10-05 | Foamix Ltd | Espuma cosmetica y farmaceutica. |
US8486376B2 (en) * | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
US20050205086A1 (en) * | 2002-10-25 | 2005-09-22 | Foamix Ltd. | Retinoid immunomodulating kit and composition and uses thereof |
US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US9211259B2 (en) * | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
US20080069779A1 (en) * | 2003-08-04 | 2008-03-20 | Foamix Ltd. | Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof |
US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
US8486374B2 (en) * | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
AU2004261063A1 (en) * | 2003-08-04 | 2005-02-10 | Foamix Ltd. | Foam carrier containing amphiphilic copolymeric gelling agent |
EP2977043A3 (en) * | 2003-08-25 | 2016-04-06 | Foamix Pharmaceuticals Ltd. | Penetrating pharmaceutical foam |
MX2009002536A (es) * | 2006-09-08 | 2009-04-14 | Foamix Ltd | Composicion espumable coloreada o coloreable y espuma. |
US20080260655A1 (en) * | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US20080206155A1 (en) * | 2006-11-14 | 2008-08-28 | Foamix Ltd. | Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses |
US20080292560A1 (en) * | 2007-01-12 | 2008-11-27 | Dov Tamarkin | Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US20090130029A1 (en) * | 2007-11-21 | 2009-05-21 | Foamix Ltd. | Glycerol ethers vehicle and pharmaceutical compositions thereof |
WO2009069006A2 (en) | 2007-11-30 | 2009-06-04 | Foamix Ltd. | Foam containing benzoyl peroxide |
WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
WO2010041141A2 (en) | 2008-10-07 | 2010-04-15 | Foamix Ltd. | Oil-based foamable carriers and formulations |
AU2009205314A1 (en) | 2008-01-14 | 2009-07-23 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
ES2330291B1 (es) * | 2008-02-29 | 2010-10-18 | Lipotec Sa | Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas. |
ES2336995B1 (es) * | 2008-10-13 | 2011-02-09 | Lipotec, S.A. | Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas. |
CA2760186C (en) | 2009-04-28 | 2019-10-29 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
CA2769677A1 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
WO2011039638A2 (en) | 2009-10-02 | 2011-04-07 | Foamix Ltd. | Topical tetracycline compositions |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
US8174881B2 (en) | 2009-11-24 | 2012-05-08 | Micron Technology, Inc. | Techniques for reducing disturbance in a semiconductor device |
FR2956115B1 (fr) | 2010-02-05 | 2012-04-06 | Isp Investments Inc | Nouveaux peptides activateurs de la caspase-14 et compositions les comprenant |
US20110280850A1 (en) * | 2010-05-12 | 2011-11-17 | Starr Elizabeth I | Compositions Containing DNA Repair Enzyme And Anogeissus Extract |
US10758630B2 (en) | 2010-08-13 | 2020-09-01 | The Johns Hopkins University | Topical compositions and methods of detection and treatment |
US20120237494A1 (en) * | 2010-09-30 | 2012-09-20 | Daly Susan M | Compositions Containing Zinc PCA And Anogeissus Extract |
ES2397890B1 (es) * | 2011-03-25 | 2014-02-07 | Lipotec, S.A. | Péptidos útiles en el tratamiento y/o cuidado de la piel y/o mucosas y su uso en composiciones cosméticas o farmacéuticas. |
ES2392283B1 (es) * | 2011-05-11 | 2013-12-10 | Laboratorios Starga S.L. | Composicion cosmetica para el cuidado de la cuperosis mejorada. |
WO2013025986A2 (en) * | 2011-08-17 | 2013-02-21 | Basf Corporation | Marine based cosmetic active ingredients and use thereof |
KR101363455B1 (ko) * | 2011-09-09 | 2014-02-21 | (주)케어젠 | 매트릭스 메탈로프로테아제 활성 억제 펩타이드 및 이의 용도 |
CN104254339B (zh) * | 2012-04-16 | 2020-01-21 | 路博润高级材料公司 | 用于治疗和/或护理皮肤和/或粘膜的化合物和它们在化妆品组合物或药物组合物中的用途 |
KR101437237B1 (ko) * | 2012-12-10 | 2014-10-30 | 미원상사주식회사 | 피부노화 방지용 테트라펩타이드 및 이를 함유하는 화장료 조성물 |
AU2014234314B2 (en) | 2013-03-21 | 2018-02-15 | Sanofi-Aventis Deutschland Gmbh | Synthesis of cyclic imide containing peptide products |
US10087221B2 (en) | 2013-03-21 | 2018-10-02 | Sanofi-Aventis Deutschland Gmbh | Synthesis of hydantoin containing peptide products |
EP3131524A4 (en) * | 2014-04-18 | 2018-01-03 | Gregory P. Pilant | Methods and compositions for topical delivery for skin care |
FR3023164B1 (fr) * | 2014-07-03 | 2017-10-20 | Expanscience Lab | Extraits peptidiques de lupin et fermete de la peau |
MX2017005597A (es) | 2014-10-31 | 2017-06-23 | Lubrizol Advanced Mat Inc | Pelicula de poliuretano termoplastico para la liberacion de agentes activos a superficies de piel. |
KR101744959B1 (ko) * | 2014-12-05 | 2017-06-12 | (주)케어젠 | 피부상태 개선 활성을 갖는 펩타이드 및 이의 용도 |
WO2017079248A1 (en) | 2015-11-05 | 2017-05-11 | Lubrizol Advanced Materials, Inc. | Thermoformable dual network hydrogel compositions |
BR112018015897B1 (pt) | 2016-02-04 | 2022-03-03 | Alastin Skincare, Inc | Composição tópica anidra para promover a reparação da pele, composições tópicas para promover a restauração da pele, composição tópica para aliviar contusões causadas por um procedimento cosmético e uso das mesmas |
US10493020B2 (en) | 2016-04-14 | 2019-12-03 | The Procter & Gamble Company | Method of improving the appearance of periorbital dyschromia |
US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
US11266344B2 (en) | 2016-09-21 | 2022-03-08 | Samsung Electronics Co., Ltd. | Method for measuring skin condition and electronic device therefor |
AU2018309058B2 (en) | 2017-08-03 | 2023-02-16 | ALASTIN Skincare, Inc. | Compositions and methods for ameliorating skin laxity and body contour |
KR102311724B1 (ko) | 2017-09-15 | 2021-10-13 | (주)아모레퍼시픽 | 슈도알터로모나스 펩티도라이티카의 배양물 또는 이의 추출물을 포함하는 피부 미백용 조성물 |
KR102395984B1 (ko) | 2017-09-27 | 2022-05-11 | (주)아모레퍼시픽 | 슈도알터로모나스 카라기노보라의 배양물 또는 이의 추출물을 포함하는 피부 미백용 조성물 |
CN107898658A (zh) * | 2017-12-13 | 2018-04-13 | 南昌师范学院 | 六胜肽祛皱增效原液组合物 |
KR102111025B1 (ko) * | 2018-06-05 | 2020-05-15 | 고려대학교 산학협력단 | 신경줄기세포 배양액을 유효성분으로 함유하는 항노화 또는 주름억제용 화장료 조성물 및 이의 제조 방법 |
WO2020028694A1 (en) | 2018-08-02 | 2020-02-06 | ALASTIN Skincare, Inc. | Liposomal compositions and methods of use |
CN109010113B (zh) * | 2018-08-28 | 2021-08-17 | 高宝化妆品(中国)有限公司 | 一种修复敏感肌肤的组合物及其应用 |
US20230320967A1 (en) * | 2020-09-11 | 2023-10-12 | Chemyunion Ltda. | Composition, use of the composition, cosmetic method for modulating the production of sebum |
EP4281034A1 (en) | 2021-01-24 | 2023-11-29 | Forrest, Michael, David | Inhibitors of atp synthase - cosmetic and therapeutic uses |
CN115340592A (zh) * | 2021-09-09 | 2022-11-15 | 禾美生物科技(浙江)有限公司 | 一种活性肽及其相关用途 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998008815A1 (en) | 1996-08-28 | 1998-03-05 | The Procter & Gamble Company | Substituted cyclic amine metalloprotease inhibitors |
JP2002515898A (ja) | 1997-02-25 | 2002-05-28 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | ヒトの皮膚での経時老化を防止および治療するための方法および組成物 |
AU751880B2 (en) * | 1997-06-25 | 2002-08-29 | Novozymes A/S | A modified polypeptide |
FR2778558B1 (fr) | 1998-05-12 | 2001-02-16 | Oreal | Utilisation d'inhibiteur de metalloproteinases pour induire et/ou stimuler la croissance des cheveux ou des poils et/ou freiner leur chute |
US6906036B2 (en) * | 2001-08-16 | 2005-06-14 | Kimberly-Clark Worldwide, Inc. | Anti-aging and wound healing compounds |
US7094754B2 (en) * | 2001-08-16 | 2006-08-22 | Kimberly-Clark Worldwide, Inc. | Anti-aging and wound healing compounds |
US7186693B2 (en) * | 2001-08-16 | 2007-03-06 | Kimberly - Clark Worldwide, Inc. | Metalloproteinase inhibitors for wound healing |
WO2004033668A2 (en) * | 2002-10-10 | 2004-04-22 | Diversa Corporation | Proteases, nucleic acids encoding them and methods for making and using them |
CN1314704C (zh) * | 2002-11-20 | 2007-05-09 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 基质金属蛋白酶2的小肽抑制剂 |
ES2330291B1 (es) * | 2008-02-29 | 2010-10-18 | Lipotec Sa | Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas. |
-
2008
- 2008-02-29 ES ES200800597A patent/ES2330291B1/es not_active Expired - Fee Related
-
2009
- 2009-02-27 SI SI200930509T patent/SI2254908T1/sl unknown
- 2009-02-27 JP JP2010548031A patent/JP5613062B2/ja not_active Expired - Fee Related
- 2009-02-27 ES ES09715427T patent/ES2399581T3/es active Active
- 2009-02-27 DK DK09715427.2T patent/DK2254908T3/da active
- 2009-02-27 KR KR1020107021674A patent/KR101656533B1/ko active IP Right Grant
- 2009-02-27 PL PL09715427T patent/PL2254908T3/pl unknown
- 2009-02-27 EP EP09715427A patent/EP2254908B1/en not_active Not-in-force
- 2009-02-27 PT PT97154272T patent/PT2254908E/pt unknown
- 2009-02-27 WO PCT/EP2009/001419 patent/WO2009106343A1/en active Application Filing
- 2009-02-27 MX MX2010009485A patent/MX2010009485A/es active IP Right Grant
- 2009-02-27 CN CN200980114319.4A patent/CN102015764B/zh not_active Expired - Fee Related
- 2009-02-27 US US12/920,241 patent/US9315564B2/en active Active
- 2009-02-27 CA CA2716650A patent/CA2716650A1/en not_active Abandoned
- 2009-02-27 AU AU2009218680A patent/AU2009218680B2/en not_active Ceased
- 2009-02-27 BR BRPI0906064A patent/BRPI0906064B8/pt active IP Right Grant
-
2010
- 2010-08-26 IL IL207808A patent/IL207808A/en not_active IP Right Cessation
- 2010-09-28 ZA ZA2010/06889A patent/ZA201006889B/en unknown
-
2011
- 2011-05-30 HK HK11105363.5A patent/HK1151301A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP5613062B2 (ja) | 2014-10-22 |
AU2009218680B2 (en) | 2013-11-21 |
WO2009106343A1 (en) | 2009-09-03 |
EP2254908A1 (en) | 2010-12-01 |
MX2010009485A (es) | 2011-02-15 |
JP2011514891A (ja) | 2011-05-12 |
ES2330291A1 (es) | 2009-12-07 |
CN102015764A (zh) | 2011-04-13 |
BRPI0906064B1 (pt) | 2020-04-14 |
IL207808A (en) | 2014-02-27 |
CA2716650A1 (en) | 2009-09-03 |
ES2330291B1 (es) | 2010-10-18 |
ZA201006889B (en) | 2011-05-25 |
IL207808A0 (en) | 2010-12-30 |
KR101656533B1 (ko) | 2016-09-09 |
US20110002969A1 (en) | 2011-01-06 |
PL2254908T3 (pl) | 2013-04-30 |
BRPI0906064A2 (pt) | 2015-06-30 |
EP2254908B1 (en) | 2012-11-21 |
AU2009218680A1 (en) | 2009-09-03 |
US9315564B2 (en) | 2016-04-19 |
PT2254908E (pt) | 2013-01-25 |
HK1151301A1 (en) | 2012-01-27 |
SI2254908T1 (sl) | 2013-06-28 |
DK2254908T3 (da) | 2013-03-04 |
ES2399581T3 (es) | 2013-04-02 |
KR20120058371A (ko) | 2012-06-07 |
CN102015764B (zh) | 2014-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0906064B8 (pt) | peptídeo, processo para obtenção de um peptídeo de fórmula geral (i), composição cosmética ou farmacêutica e uso de um peptídeo de fórmula geral (i) | |
BRPI0913831B8 (pt) | peptídeo com a fórmula geral (i), seus estereoisômeros, suas misturas, ou seus sais cosmética ou farmaceuticamente aceitáveis, processo para a preparação de um peptídeo com a fórmula geral (i), seus estereoisômeros, suas misturas, ou seus sais cosmética ou farmaceuticamente aceitáveis e composição cosmética ou farmacêutica | |
BR112013020005A2 (pt) | peptídeo de fórmula geral r1-wn-xm-aa1-aa2-aa3-aa4-aa5-aa6-yp-zq-r2, seus estereoisômeros, misturas dos mesmos e/ou seus sais cosmética ou farmaceuticamente aceitáveis e composição cosmética ou farmacêutica | |
Pham et al. | Anti‑wrinkle effect of fermented black ginseng on human fibroblasts | |
MX2011010859A (es) | Peptidos utiles en el tratamiento y/o cuidado de la piel y/o cabello y su uso en composiciones cosmeticas o farmaceuticas. | |
MX2011008616A (es) | Peptidos utiles en el tratamiento y/o cuidado de la piel , mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas. | |
TW201129368A (en) | Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions | |
BRPI0910874B8 (pt) | formulação tópica para uso no tratamento tópico de uma condição da pele que resulta da produção de espécies reativas de oxigênio e/ou para a promoção da cicatrização de ferida tópica na pele de um indivíduo e uso da referida formulação | |
BR112018011643A2 (pt) | composto, composição cosmética ou farmacêutica, uso de um composto, e, método para tratamento e/ou cuidado não terapêutico e cosmético da pele, cabelo, unhas e/ou membranas mucosas. | |
BR112013000920A2 (pt) | compostos para a redução de produção de beta-amiloide | |
ATE533795T1 (de) | Neutralisiertes kationisches polymer, zusammensetzung mit dem besagten polymer und kosmetisches behandlungsverfahren | |
RU2015122627A (ru) | Кожные композиции, содержащие неприродные гигроскопические аминокислоты | |
BR112019007420A2 (pt) | composto, uso de um composto, composição cosmética ou farmacêutica, e, método cosmético não terapêutico de tratamento e/ou cuidado da pele, do cabelo, das unhas e/ou das membranas mucosas | |
BR112015012565A2 (pt) | composto, composição cosmética ou farmacêutica, e, uso de um composto | |
BR112012012996A2 (pt) | extrato de grãos de acácia macrostachya e composições que o compreende | |
BR112015022096A8 (pt) | compostos moduladores de canal de sódio, composição que os compreende e uso dos mesmos | |
BRPI0412815A (pt) | extrato de plantas com eficácia prebiótica | |
BR112012009376A2 (pt) | composição farmacêutica, forma de dosagem farmacêutica, processo para a sua preparação, métodos de tratamento e seu uso | |
BR112015014501A2 (pt) | aminoácido de zinco/halogeneto de trimetilglicina | |
ES2397889A1 (es) | PÉPTIDOS MODULADORES DE PGC-1Alfa. | |
BR112015005339A8 (pt) | uso de óleo de semente de fruta milagrosa como um ingrediente ativo | |
BR112013031652A2 (pt) | métodos de tratamento para doenças retinais | |
AU2012390200A1 (en) | Use of pedf-derived polypeptides for preventing and/or ameliorating skin aging | |
CY1115734T1 (el) | Συνθεσεις benzenesulfonamide, μεθοδος συνθεσης τους, και χρηση αυτων στην ιατρικη | |
BRPI0514030A (pt) | derivados de ácido hidroxámico substituìdo por arilssulfonamida, como inibidores de metaloproteinases de matrizes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 14/04/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/02/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |